Ob/Gyn Updated
Your Web destination for the latest in Evidence based Obstetrics, Gynecology and Women’s health.
Showing posts with label
aromatase inhibitors
.
Show all posts
Showing posts with label
aromatase inhibitors
.
Show all posts
Friday, June 23, 2017
Novartis Breast Cancer drug Kisqali wins market approval in European Union as first-line treatment for HR+/HER2-
›
European Medicines Agency (EMA) panel approves Kisqali (CDK4/6 inhibitor ribociclib) in combination with hormone therapy as a first-l...
Saturday, December 24, 2016
Current options for ovulation induction in Polycystic Ovarian Syndrome (PCOS).
›
Image courtesy: pcosdatabase.org Polycystic Ovarian Syndrome (PCOS) affects 1 in 10 women of childbearing age and have important me...
13 comments:
Wednesday, June 15, 2016
ACOG updates the recommendations for use of aromatase inhibitors in gynecology practice.
›
Aroma-tase is a microsomal cytochrome P450 hemoprotein-containing enzyme with a wide expression in different kind of tissues like ovary, t...
›
Home
View web version
